Insight

An update on the development of HER2-targeted therapies

Photo taken from ghealth121.com

Jul 25, 2024, 01:39

An update on the development of HER2-targeted therapies

Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared on X:

“HER2-targeted therapies beyond breast cancer – an update on Nature Reviews Clinical Oncology an update on the current development landscape of HER2-targeted therapies, as well as anticipated future HER2-directed treatment strategies to overcome resistance and thereby improve efficacy and patient outcomes.”

HER2-targeted therapies beyond breast cancer – an update | Nature Reviews Clinical Oncology

Autors: Jeesun Yoon and Do-Youn Oh

HER2-targeted

Source: Elisabetta Bonzano/X

Breast Cancer cancer Do-Youn Oh Elisabetta Bonzano HER2-targeted therapy Jeesun Yoon Nature Reviews Clinical Oncology OncoDaily Oncology radiation oncology

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Special Coverage